Introduction
Both prostate cancer and benign prostatic hyperplasia are believed to arise as a result of changes in the balance between cell proliferation and differentiation. 1, 2 Discovering what controls the differentiation process is therefore vital to the understanding of prostatic disease development. There are three types of epithelial cells in the prostate: basal, luminal and neuroendocrine, all of which are believed to be derived from a common stem cell. This review will examine how far we have come in our hunt to identify the prostate stem cell.
Stem cells
Stem cells are required for the maintenance of high cell turnover tissues where cells continually need to be replaced. The stem cells with the highest ability to regenerate different tissues are embryonic stem cells. First isolated from mouse embryos in 1981, a great deal of excitement was generated by the discovery that these cells were able to give rise to differentiated cell types from all three embryonic germ-cell layers (pluripotency). Following reports that such cells could also be cultured from human foetal tissue, 3, 4 there has been a flood of interest in the potential therapeutic use of these cells. Since the use of foetal tissues is beset with ethical questions, it has become desirable to examine the ability of adult tissue stem cells to fulfil a role in tissue repair and many groups have explored this area. Pluripotency is unique to the embryonic stem cell and adult stem cells are generally multipotent, producing progeny with a more limited range of cells types. The best understood of these tissues is the bone marrow in which a common primitive haematopoietic stem cell gives rise to multiple blood cell types, of both myeloid and lymphoid lineages. 5 Stem cells in most tissues, however, generate an even more limited repertoire of cell lineages. In the gut, crypt stem cells differentiate in two directions to generate paneth and enterocyte cells, 6 while, in the skin, keratinocyte stem cells produce either epidermal keratinocytes or the various cell types of the hair follicle. 7 Several studies have explored the potential use of stem cells to treat disease. The ability to purify haematopoietic stem cells based on cell surface markers makes it possible to regenerate blood-forming and immune systems, 8 while the isolation of stem cells from tissues such as the liver, kidneys and skin may allow stem-cell-based tissue repair. Additionally, bone marrow stem cells have recently been shown to be capable of transdifferentiating into other cell types including neuronal, 9 hepatic 10 and renal cells, 11 and the ability to repair one tissue with stem cells from another is becoming an exciting possibility.
In all tissues studied, stem cells constitute a small population of relatively undifferentiated cells that express none of the keratin or other differentiation lineage markers of the tissue. Typically, stem cells are slow cycling in that they divide relatively rarely but they are self-renewing, each cell division producing an average of one stem cell and one transit-amplifying (TA) cell. The TA cell has limited proliferative capacity in that, although it may divide rapidly, once its proliferative potential is exhausted it will undergo terminal differentiation. This differentiation often produces the functional cells of the tissue, such as the secretory lining of a gland or the protective outer layer of the epidermis. The ability of the progeny of stem cells to produce differentiated cells of different lineages is termed pleuripotency. This is shown diagrammatically in Figure 1 .
The slow cycling characteristic of stem cells has been investigated using the identification of label-retaining cells (LRCs) in mouse tissues. 12 Tissues are labelled with a DNA precursor such as tritiated thymidine or bromodeoxyuridine and, following a long chase period only cells that have divided slowly will retain label within their DNA, the label being lost from the remaining cells to daughter cells upon cell division. LRCs have been localised to the bulge region of the hair follicle, 13, 14 to the limbus of the cornea of the eye 15 and, more recently, to the urethral proximal region of mouse prostatic ducts. 16 
Stem cells and prostate disease
Since the prostate is not essential for human survival, the interest in prostate stem cells lies, not in the potential for tissue regeneration, but as targets for the treatment of prostate disease. Among several theories for the causes of benign prostatic hyperplasia (BPH) is the suggestion that it involves an expansion of the stem cell population. 1 Even a small change in stem-cell numbers would be amplified through the additional TA cell divisions resulting in epithelial expansion. Alternatively, it is possible that the stem-cell number may remain constant, but the TA cells may acquire the ability to divide more times before undergoing terminal differentiating. Before we can determine which of these, if either, is involved we need to be able to identify the stem cells and their progeny. There is currently a return to the belief that cancer is also a disease involving a stem-cell-based differentiation hierarchy. 17 Tumour cells in culture demonstrate a high degree of proliferative heterogeneity, [18] [19] [20] and there is histological evidence for a subpopulation of less-differentiated cells in prostate tumours that may represent cancer stem cells. 21, 22 An important aspect of prostate cancer treatment is that androgen ablation kills tumour cells and alleviates the symptoms associated with tumour load but more basallike androgen-independent cells survive. It is possible that an androgen-independent cancer stem cell survives and continues to divide but its androgen-dependent progeny die. With time, the stem cell may acquire further mutations that allow its progeny to become androgen independent and the tumour returns. It would therefore be advantageous to target cancer stem cells. It is not known, however, if cancer stem cells resemble normal stem cells, 2 TA cells 21, 23 or dedifferentiated luminal cells 24, 25 and, as with BPH, we need definitive stem-cell markers to address this question.
Evidence for adult prostate stem cells
Much of the earliest evidence for the existence for stem cells in the normal prostate came from observations that emerged from androgen-ablation studies in both human and rodents. Following castration, there is a rapid reduction in the volume of the prostate and most of this loss is due to apoptosis of cells in the luminal layer. The remainder of the epithelial population can survive for long periods of time and, following androgen replacement, the prostate can be regenerated to its original size and function. [26] [27] [28] [29] These observations led to the development of a stem-cell theory for prostate that postulated that an androgen-independent stem cell produces androgen-independent TA cells that, in turn give rise to androgen-dependent fully differentiated luminal secretory cells. 1 
Keratin expression defines an epithelial cell differentiation pathway
The prostate gland is comprised of a complex branching ductal structure embedded within a muscular stroma containing smooth muscle and fibroblasts together with neurovascular components (Figure 2a ). The glandular epithelium consists of two cell layers: proliferation is confined largely to the basal layer, Some cells express a phenotype intermediate between that of basal and luminal cells 21, 34, 35 and we demonstrated that these cells have a distinct keratin expression pattern. Using simultaneous immunofluorescent staining of prostate tissues for up to three keratins, we identified a distinct population of basal cells that did not express K14 but did express both K17 and K19. K19 was also expressed by some of the luminal cells and by cells that appeared to be located midway between the basal and luminal cell layers. This led us to propose a keratin-based differentiation pathway 30 ( Figure 3) . A stem-cell popula- Neuroendocrine cells have been shown to express either basal or luminal keratin patterns along with neuroendocrine peptides and so they are generally accepted to originate from the same common stem cell as the basal and luminal cells. 2 In order to find proof of the existence of stem cells and to further characterise them it became necessary to develop methods for the clonal growth of prostate cells in culture and this will be discussed below.
Prostate epithelial stem cells in culture
Prostate cell culture methods were initially described several years ago, 37, 38 but in recent years methods of separating epithelial cells from the stromal tissue 39, 40 together with the development of new serum-free media 40 has allowed us to develop ways of growing the cells at clonal densities, allowing the study of the proliferative potential of individual cell populations.
We developed a growth assay system using freshly isolated prostate epithelial cells plated at clonal density on a feeder layer of irradiated mouse 3T6 cells. Primary cells isolated from BPH tissue had a colony-forming efficiency of approximately 6% of plated cells 41 with two main types of epithelial colony formed that were termed type I and II. The majority of colonies, type I, were irregular in shape, containing between 32 and 8500 cells after 14 days in culture and these had a cell density of around 30 cells per linear mm (Figure 2c ). Type II colonies were larger on average than type I colonies containing between 8000 and 40 000 cells after 14 days 42 showed that 2-4% of freshly isolated mouse prostate epithelial cells gave rise to colonies and, as for human, two distinct colony types were formed. Cells from one colony type, described as star-shaped, were able to form new colonies on replating, while the cells from a second colony type, termed discshaped, could not. They proposed that, as described for human, colonies with self-replicative ability were the progeny of stem cells, while the less-proliferative colonies were derived from TA cells.
Stem-cell pluripotency
Although cells grow very well in monolayer culture, cells grown in this way rapidly lose their ability to produce fully functional differentiated cell progeny. This is largely due to the loss of physiological cell-cell interactions present in three-dimensional tissues. In order to study differentiation, it is therefore desirable to use a model culture system that more closely mimics the in vivo situation. One of the more successful systems for epithelial cells that has been used is the suspension of cells in a semisolid medium called Matrigel, a reconstituted extracellular membrane produced by Englebroth-Holm-Swarm (EHS) mouse sarcoma cells. 43 Matrigel has been widely used to study epithelial differentiation in breast epithelial cell lines 44 and in prostate. 45 Since one of the definitions of a stem cell is pluripotency, the ability to produce different cell types, we used Matrigel to examine the capacity of our putative stem-cell population to fully differentiate. 41 Cells that had been grown for 14 days, as described above, were harvested and cells derived from single type II colonies were cultured on Matrigel in the presence of androgen and stromal cell-conditioned medium. Over a period of 3-17 days clumps of cells developed into threedimensional spherical structures with side branches (Figure 2e ) that often appeared to be connected by cellular duct-like structures.
Immunostaining sections of the spherical structures showed a well-organised multilayered structure with a basal layer and one or more luminal cell layers. The outermost layer expressed basal cell markers keratins 5 ( Figure 2f ) and 14 ( Figure 2h ) along with CD44 (Figure 2g ), while the luminal cells stained preferentially for putative TA cell markers K17 (Figure 2i ) and K19 together with K8. 41 There were cells that had been shed into the luminal spaces of the spheroids and these stained positively for the androgen receptor, normally expressed by fully differentiated luminal cells. We failed to observe secretory function in these spheroids, with no expression of PSA or PAP, but this may be due to a requirement for further stromal-cell-derived signals that are not present in the conditioned medium. The importance of stromal/epithelial interactions in normal prostate growth and differentiation has been demonstrated both in vivo 46 and in vitro 47 and Collins et al 48 showed that a stem-cell-enriched population of cells could produce three-dimensional structures with basal cells and fully secretory differentiated luminal cells, when engrafted into athymic male mice in the presence of human stromal cells. More recently, Lang et al 49 showed that differentiation in Matrigel could be further improved by the addition of serum and oestrogen.
Regulators of stem-cell self-renewal and differentiation
In order to maintain the homeostasis of a tissue, there must be a finely tuned balance between division of stem and TA cells and loss of cells through differentiation or apoptosis. This is established in many different ways; through interactions between adjacent cells, through interactions with the extracellular matrix or through the effects of soluble factors from the local environment.
The stem-cell niche
One way in which stem-cell self-renewal is controlled is through the establishment of a niche, a specialised localisation where stem cells are held, either by local expression of specific adhesion molecules or by external signals that maintain the stem cells in a quiescent state (reviewed by Fuchs et al
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). Although there is limited evidence that many of these are involved in prostate stem-cell maintenance, the conservation of their involvement in different tissues from different species makes it likely that similar systems are involved. Integrins, Notch1 and TGFb are involved in control mechanisms regulating stem-cell niches in other tissues and there is increasing evidence that they may be relevant in the prostate.
Integrins
Stem cells in other epithelial systems, such as the skin, have been shown to have high cell-surface levels of functional a2 and b1 integrins and have been isolated on the basis of their rapid adherence to type I collagen and to other extracellular matrix (ECM) proteins. 51 In the skin, clusters of integrin bright keratinocytes are found at the tips of the dermal papillae in interfollicular scalp and foreskin, while in palm skin they are located at the tips of deep rete ridges. 52 This localisation implies a stem-cell niche, in which the expression levels of adhesion molecules dictate the position of the stem cells. Loss of cell surface integrins signals a withdrawal from the stemcell niche and ultimately differentiation. 53, 54 Although
Prostate epithelial stem cells DL Hudson there is no evidence for a stem-cell niche in adult human prostate, we, and others, have analysed the adhesion of freshly isolated prostatic epithelial cells to type I collagen and demonstrated that rapid adhesion to ECM can enrich for stem cells. 41, 48 As shown for keratinocytes, the most rapidly adhering cells had the highest proliferative capacity with up to 80% of colony-forming cells attaching within 20 min. However, when we analysed the types of colony formed, we found that cells producing type I or type II colonies attached at the same rate. The preferential attachment of colony-forming cells did, however, represent a five-fold enrichment for both stem and TA cells compared to nonproliferative cells. Collins et al 48 went on to show that the most rapidly attaching cells had the highest levels of cell surface a2 integrin and that integrin-bright epithelial cells were distributed throughout the basal layer as single cells rather than in clusters.
Notch/Delta
Another way in which keratinocytes maintain the stemcell hierarchy is by the expression of the Notch receptor and its ligand Delta1. Notch is known to be involved in regulating differentiation both in development 55 and in the adult. 56 Keratinocyte stem cells express higher levels of Deltal than TA cells and signal to their neighbours to enter the differentiation pathway. 57 Although there is no evidence for an involvement for Notch signalling in human prostate stem-cell regulation, a recent study showed that Notch1 is highly expressed in basal cells during prostate development. 58 Wang and colleagues also showed that Notch1 is downregulated in adult tissue but is upregulated in some cells during tumorigenesis of the TRAMP mouse model. 59 Notch1 was also required for branching morphogenesis during development as well as regeneration following androgen ablation.
TGF-b
TGF-b is produced by smooth muscle cells 60 that surround the proximal region of prostatic ducts. 61 This region was recently shown to contain label-retaining putative stem cells 16 and the authors proposed that stromally derived TGF-b may act as an inhibitor to prostate stem-cell proliferation. This work provides evidence for a prostate stem-cell niche with quiescent stem cells concentrated at the urethral proximal region of prostatic ducts and proliferative, TA cells located in more distal regions. Corresponding with this, a gradient in TGF-b expression has been shown to exist, with lowest expression in distal regions of ducts. 61 Furthermore, the absence of either TGF-b 62 or the TGF-b type II receptor (TbRII) 63 induces excessive prostatic epithelial growth and, in the case of TbRII, neoplasias.
In addition to those possibly involved in stem-cell niches, several other proteins have also been postulated to play a role in maintainence of prostatic stem cells. Some, such as p27 kip1 are expressed by a subset of basal cells while others, such as Bcl-2 and p63, by all basal cells. While not providing markers for stem cells, these may be involved in maintenance of the proliferative compartment and in controlling entry into the differentiation pathway.
Expression of Bcl-2, a protein with antiapoptotic activity 64, 65 is expressed only by basal cells in the prostate and its absence in luminal cells 66 may allow androgen-regulated differentiation and apoptosis. Interestingly, Bcl-2 expression can be used as a prognostic marker in early prostate cancer 67 and may be involved in hormone-independent cancer. 68 A homologue of the tumour suppressor gene p53, 69 p63 is a protein expressed by basal cells that is essential for the development of most squamous epithelia. p63 null mice (p63 À/À ) are born without limbs or epithelial organs such as the mammary, salivary and prostate glands and die soon after birth. [70] [71] [72] The expression in the whole basal layer suggests that p63 is expressed by both stem and TA cells and may be involved in controlling the progression from proliferation to differentiation.
The cyclin-dependent kinase (cdk) inhibitor p27 kip1 functions as a negative cell-cycle regulator and has been shown to be involved in growth arrest during cellular differentiation (reviewed by Sgambato et al
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). In the prostate, it is expressed in nearly all luminal cells with heterogenous expression in the basal layer. 22 De Marzo et al 22 proposed that expression of p27 kip1 in a subpopulation of basal cells is related to stem-cell quiescence and that lack of p27 kip1 may be a marker of normal TA cells.
Conclusions
There have been significant advances in recent years in our ability to culture prostate cells and to study the stemcell biology of the human prostate. It has been shown that approximately 2-3% of basal epithelial cells have characteristics of stem cells. To date, however, there are no in situ markers for these cells. One characteristic of haematopoietic stem cells is their ability to efflux a DNAbinding fluorescent dye, Hoechst 33342. The dye is actively expelled from primitive or stem cells by a multidrug resistance protein (MDR1) and this functional marker identifies a side population (SP) of cells in flow cytometric analysis. 74 SP cells have been identified in a range of epithelial tissues including keratinocytes, 75 breast 76 and recently in prostate. 77 Although more work is required to prove that these cells represent a stem-cell population, it does represent an important step towards their characterisation. Recent advances in the use of gene expression profiling, using techniques such as cDNA microarray make it likely that definitive stem-cell markers will be available in the near future.
We are entering an exciting time in prostate stem-cell research and it seems highly likely that we will soon be able to address the questions regarding the role of stem cells in BPH and prostate cancer.
